

Computational oncology and multi-omics data leader with deep expertise in tumor microenvironment biology, cancer immunology, biomarker discovery, and translational research. Author of 100+ peer-reviewed publications with an h-index of 18+, focused on translating genomic, transcriptomic, blood-based, and immune profiling data into clinically relevant insights across oncology and immune-mediated diseases.
Expertise includes RNA-seq, WES, blood-based molecular testing, AI-enabled omics interpretation, patient stratification, and multi-modal data integration across scRNA-seq, flow cytometry, and multiplex immunofluorescence. Proven experience leading cross-functional scientific teams, external collaborations, and research-to-product initiatives in precision oncology.